Polyol pathway, 2,3-diphosphoglycerate in erythrocytes and diabetic neuropathy in rats

Author： Nakamura J.   Koh N.   Sakakibara F.   Hamada Y.   Wakao T.   Hara T.   Mori K.   Nakashima E.   Naruse K.   Hotta N.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.294, Iss.1, 1995-01, pp. : 207-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relationship between chronic disturbance of 2,3-diphosphoglycerate metabolism in erythrocytes and Alzheimer disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 1, 2016-02 ,pp. : 113-123

Bentham Science Publishers

Access to resources Recommend Favorite

AS 3201 inhibits polyol pathway in diabetic polyneuropathy

By  

Inpharma, Vol. 1, Iss. 1459, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Cyclooxygenase-2 Pathway as a Potential Therapeutic Target in Diabetic Peripheral Neuropathy

By  

Current Drug Targets, Vol. 9, Iss. 1, 2008-01 ,pp. : 68-76

Bentham Science Publishers

Access to resources Recommend Favorite

A novel zwitterionic inhibitor of aldose reductase interferes with polyol pathway in ex vivo and in vivo models of diabetic complications

By  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 10, 2014-10 ,pp. : 747-751

Govi-Verlag

Access to resources Recommend Favorite

Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats

By Yu Junxian   Zhang Yindi   Sun Shi   Shen Jianping   Qiu Jun   Yin Xiaoxing   Yin Honglin   Jiang Shaojun  

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 6, 2006-06 ,pp. : 579-587

NRC Research Press

Access to resources Recommend Favorite